Last reviewed · How we verify
NCT05894642
Characterization of Long Covid Pain in Primary Care
trial testing 0 in Long COVID in 300 participants. Status unknown.
1 December 2023
Quick facts
| Lead sponsor | University of Valladolid |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 300 |
| Start date | 15 May 2022 |
| Primary completion | 1 December 2023 |
| Estimated completion | 1 February 2024 |
| Sites | 1 location across Spain |
Drugs / interventions tested
- 0
Conditions studied
- Long COVID — all drugs for Long COVID →
- Chronic Pain — all drugs for Chronic Pain →
- Musculoskeletal Pain — all drugs for Musculoskeletal Pain →
Sponsor
University of Valladolid
Who can join
Adults 18 to 70, any sex, with Long COVID or Chronic Pain. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Justification: among the sequelae of Covid-19 in clinical practice we frequently find persistent neuromusculoskeletal pain. Prevalence data and the underlying mechanisms of such pain are very limited in the scientific literature. Therefore, with this research we will try to answer these questions. Main objective: to determine and characterize persistent musculoskeletal pain in Covid-19 patients. Method: two phases. First, a descriptive cross-sectional study will be carried out to estimate the prevalence of Long Covid Pain (LCP). Second phase, a case-control study will be carried out using the sample obtained in the first phase as the population. The sample will be divided into two groups: post-Covid-19 patients with LCP and post-Covid-19 patients without persistent pain (control group). The two groups will be matched according to sex, age and level of severity of the pathology. An assessment and comparison between groups will be made of the following variables: central sensitization, healthy physical condition and blood test values, which will be evaluated by means of physical examination, questionnaires and laboratory tests. Applicability of the results: this is a pioneering project at the national level, which would determine more reliably the prevalence of LCP in postcovid and could be a first step in the search for the best therapeutic strategies for these patients. This would help to improve the quality of life of these patients and to better manage the social and healthcare resources used in their treatment.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05894642
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of 0
Trials testing the same drug.
- NCT04451005 — Diagnostic Evaluation of Sarcopenia in Elderly Patients · completed
Other recruiting trials for Long COVID
Currently open trials in the same condition.
- NCT05931497 — Sauna for Long Covid · NA · recruiting
- NCT06452095 — Recovering From COVID-19 Lingering Symptoms Adaptive Integrative Medicine Trial - Effect of Hyperbaric Oxygen Therapy fo · NA · recruiting
- NCT07316127 — Immunoadsorption in Autoimmune Long COVID · Phase 2 · recruiting
- NCT07435805 — Long-Term Health Effects of Previous COVID-19 in Patients Undergoing Preoperative Anesthesia Evaluation · recruiting
- NCT07278206 — Brain Stimulation in Long COVID · NA · recruiting
Other University of Valladolid trials
Trials by the same sponsor.
- NCT07302191 — High-Intensity Interval or Concurrent Exercise on Oxidative Stress and Inflammation in Obese Women · NA · completed
- NCT07307391 — Exercise in Extreme Hot Weather Conditions · NA · completed
- NCT06696378 — Melatonin Supplementation and Exercise Program in Breast Cancer Women · NA · recruiting
- NCT06616181 — TDCS and Tele-rehabilitation Exercise in Fibromyalgia · NA · not yet recruiting
- NCT06326229 — Clinical Validation of Musculoskeletal ICF Core Set in Primary Care Physiotherapy · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05894642 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Valladolid
- Last refreshed: 8 June 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05894642.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing